How do I calculate the CKD‑EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C estimated glomerular filtration rate (eGFR)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Calculate CKD-EPI Cystatin C eGFR

Use the 2021 CKD-EPI cystatin C equation, which requires only serum cystatin C (mg/L), age, and sex—no race coefficient—and is calculated as: eGFR = 133 × min(Scys/0.8,1)^-0.499 × max(Scys/0.8,1)^-1.328 × 0.996^age × 0.932 [if female], where Scys is serum cystatin C in mg/L.

Practical Implementation

The 2021 CKD-EPI equations eliminated race-based coefficients and provide three options 1:

  • Creatinine-only equation (eGFRcr): Uses serum creatinine, age, and sex
  • Cystatin C-only equation (eGFRcys): Uses serum cystatin C, age, and sex
  • Combined creatinine-cystatin C equation (eGFRcr-cys): Uses both biomarkers, age, and sex

For cystatin C-based estimation specifically, the combined creatinine-cystatin C equation demonstrates the lowest bias (0.63 mL/min/1.73 m²) and highest accuracy in most populations 2. When both biomarkers are available, this combined equation should be your first choice 1, 3.

Laboratory Requirements

Before calculating, ensure your laboratory meets these standards 1:

  • Cystatin C assay precision: Coefficient of variation <2.0%
  • Calibration: Traceable to international standard reference materials
  • Bias: <3.2% compared to reference methodology
  • Sample handling: Separate serum/plasma from red blood cells within 12 hours
  • Concurrent measurement: When measuring cystatin C, measure creatinine on the same sample to enable eGFRcr-cys calculation

Reporting Standards

Report the calculated eGFR 1:

  • Rounded to the nearest whole number
  • In units of mL/min per 1.73 m²
  • Flag values <60 mL/min per 1.73 m² as low
  • Round cystatin C concentration to the nearest 100th (e.g., 1.23 mg/L)

Performance Characteristics

The cystatin C-only equation achieved the highest accuracy (P30 = 88%) in validation studies, meaning 88% of estimates fell within 30% of measured GFR 4. The combined creatinine-cystatin C equation showed excellent agreement (0.891-0.978) across diverse populations 5 and performed optimally when measured GFR ≥60 mL/min/1.73 m² 4.

Critical Caveats

Creatinine-based equations systematically overestimate GFR in certain populations and should be used with extreme caution 4, 6:

  • Patients with neurogenic lower urinary tract dysfunction: Creatinine equations overestimated by 13-17 mL/min/1.73 m² with only 51-57% accuracy
  • Chronic intestinal failure patients on parenteral nutrition: All equations overestimated, but creatinine-only showed the worst bias (+21.1 mL/min/1.73 m²)
  • Patients with reduced muscle mass or altered creatinine metabolism

In these populations, cystatin C-based equations (either alone or combined) demonstrate superior accuracy and should be strongly preferred 4, 6.

When to Use Each Equation

Use this algorithmic approach:

  1. If both creatinine and cystatin C available: Use eGFRcr-cys (lowest bias, best accuracy) 2
  2. If only cystatin C available: Use eGFRcys (particularly accurate when measured GFR <60 mL/min/1.73 m²) 4
  3. If creatinine-based eGFR seems inaccurate: Measure cystatin C and recalculate with eGFRcr-cys 1
  4. In special populations (NLUTD, intestinal failure, extremes of muscle mass): Prioritize cystatin C-based equations 4, 6

Geographic Considerations

Use the same equation within your geographical region (continent, country, or region as defined locally) to ensure consistency in CKD staging and clinical decision-making 1. The 2021 CKD-EPI equations without race coefficients are now the recommended standard across diverse populations 7.

Related Questions

How do I calculate the CKD‑EPI cystatin C equation (and the combined creatinine‑cystatin C equation) for a 68‑year‑old female with BMI 40, cystatin C 1.2 mg/L, and serum creatinine 0.93 mg/dL?
What other factors can affect serum creatinine, creatinine-based estimated glomerular filtration rate (eGFR), and cystatin C?
What stage of chronic kidney disease (CKD) corresponds to an estimated glomerular filtration rate (eGFR) of 54 mL/min/1.73 m² and a serum creatinine of 1.14 mg/dL?
What is the estimated glomerular filtration rate using the combined creatinine‑cystatin C (CKD‑EPI) equation for a 39‑year‑old male with serum creatinine 0.9 mg/dL, cystatin C 1.16 mg/L, and low muscle mass?
What is the medical significance of mistakenly reporting a serum creatinine of 300 µmol/L instead of the true value of 1000 µmol/L in a symptomatic stage 5 chronic kidney disease patient who has refused dialysis?
Is intravenous sucrose appropriate for procedural analgesia in infants?
What is the appropriate next‑step antibiotic therapy for a patient with acute otitis media who has already received a course of amoxicillin/clavulanate (500 mg/125 mg) with the last dose on [DATE]?
What are examples of hemoglobin (Hb) variants?
In infants with iron‑deficiency anemia refractory to oral iron or when transfusion must be avoided, how should intravenous iron sucrose be used and dosed?
What is the ICD‑10 code for joint swelling treated with colchicine?
What medications can a patient with a head cold safely take while on losartan (angiotensin II receptor blocker) and chlorthalidone (thiazide diuretic)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.